Reply: To PMID 23798472

Affiliations

¹ Departments of Pediatrics and Neurology, University of Cincinnati College of Medicine and Division of Child Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Comment

Darcy Krueger et al. Ann Neurol. 2014 Jan.

. 2014 Jan;75(1):164-5.

doi: 10.1002/ana.24046. Epub 2014 Jan 2.

¹ Departments of Pediatrics and Neurology, University of Cincinnati College of Medicine and Division of Child Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

No abstract available

Comment on

Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.
Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C, Mays M, Lopez CM, Kim MO, Franz DN. Krueger DA, et al. Ann Neurol. 2013 Nov;74(5):679-87. doi: 10.1002/ana.23960. Epub 2013 Sep 10. Ann Neurol. 2013. PMID: 23798472 Clinical Trial.
Treatment of intractable epilepsy in tuberous sclerosis complex with everolimus is not yet evidence-based.
Overwater IE, Rietman AB, Elgersma Y, de Wit MC. Overwater IE, et al. Ann Neurol. 2014 Jan;75(1):163-4. doi: 10.1002/ana.24047. Epub 2014 Jan 2. Ann Neurol. 2014. PMID: 24243580 No abstract available.